Three women sue Grail alleging harassment, retaliation; can new CDC director find consensus?

Three sales executives have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed.

July 14, 2023 Check out STAT+

Sponsored By

NC Department of Public Safety In N.C., Mandy Cohen built bridges to GOP. Can she find consensus as new CDC director? Cohen had a remarkably bipartisan record in a state with a fair share of partisan rancor. But Washington could present new challenges. By Joanne Kenen STAT+ | Three women sue cancer diagnostic firm Grail alleging harassment, retaliation In a statement, a spokesman for Grail said the company was reviewing the complaints but was "confident that the claims are without merit." By Matthew Herper J&J expands global access to TB drug as popular novelist joins advocacy campaign Novelist John Green posted a video this week accusing J&J of keeping a lifesaving TB drug out of the hands of millions of people. By Abdullahi Tsanni and Jason Mast and Ed Silverman Nephron/Wikimedia Commons Celiac study examines precisely how gluten triggers injury to intestine Several types of T cells get whipped into damaging action, concludes the study, which could shed light on diseases other than celiac disease. By Isabella Cueto STAT+ | Eli Lilly to acquire Versanis in heated race for weight loss drugs Lilly said it will acquire Versanis, a private company developing an obesity drug that specifically targets fat mass, preserving muscle. By Elaine Chen STAT+ | Why hospitals are cutting ties with Moody's rating agency Some nonprofit hospitals are cutting ties with Moody's Investors Service, citing high costs, time commitment, and other gripes. By Tara Bannow Illustration: Alex Hogan/STAT; Photo: Eisai via AP STAT+ | With momentum on Alzheimer's therapies, Europe sees delivery challenges ahead, too Despite hard-won victories, the arrival of new therapies presents new challenges in Europe as countries plan for their possible rollouts. By Andrew Joseph Democrats press government to extend free Covid-19 tests indefinitely Four senators want the U.S Preventive Services Task Force to act so that insurers must cover the product with no copay for enrollees. By Sarah Owermohle

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser